Loading clinical trials...
Loading clinical trials...
CP-675,206 (tremelimumab) is a fully humanized monoclonal antibody that binds to activated T lymphocytes and by enhancing their activation may produce a stimulation of the immune response against tumo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators
NCT07607769 · Hepatocellular Carcinoma
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
NCT07478302 · Advanced Unresectable Hepatocellular Carcinoma
Hospital Universitario Reina Sofía
Córdoba
Hospital Universitario 12 de Octubre
Madrid
Clinica Universitaria de Navarra
Pamplona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions